No Detail Found!

Irinotecan and Bevacizumab in Glioblastoma-A Review.

Author(s)
M. T. Shahid Center for Research in Molecular Medicine (CRIMM), The University of Lahore, Lahore, Pakistan
S. Khair-Ul-Bariyah Department of Chemistry, Forman Christian College (A Chartered University), Lahore, Pakistan
Abstract
Glioblastoma is a common brain tumor having comparatively poor prognosis. Bevacizumab and irinotecan are found to be effective in the treatment of recurrent glioblastoma. The present review covers investigations made on the mentioned drugs in the past decade. As compared to other chemotherapeutic agents, the drugs have shown greater activity and overall survival when used as monotherapeutic agents or in combination with other drugs. Still some work needs to be done in establishing clear role of both the drugs in newly diagnosed glioblastoma, especially, role of irinotecan needs clarity.
Publication Details
Page(s) 1-5
DOI DOI not available
Published Journal: Pakistan Journal of Chemistry, Volume: 4, Issue: 1, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

30

Views